chrisvoncsefalvay/vaers-outcomes huggingface dataset:
This spontaneous case was reported by a nurse and describes the occurrence of PRODUCT TEMPERATURE EXCURSION ISSUE (Refrigeration excursions identified/undergone several temperature excursions), POOR QUALITY PRODUCT ADMINISTERED (Vaccines have undergone several temperature excursions and may have been administered to patient) and NO ADVERSE EVENT (No adverse event) in a 60-year-old male patient who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (batch no. AS7146B) for COVID-19 prophylaxis.     It was unknown if patient had ever been diagnosed or tested positive for COVID-19.     On 21-Sep-2022 at 12:30 PM, the patient received fourth dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Intramuscular) .5 dosage form. On 21-Sep-2022 at 12:30 PM, the patient experienced POOR QUALITY PRODUCT ADMINISTERED (Vaccines have undergone several temperature excursions and may have been administered to patient). On an unknown date, the patient experienced PRODUCT TEMPERATURE EXCURSION ISSUE (Refrigeration excursions identified/undergone several temperature excursions) and NO ADVERSE EVENT (No adverse event). At the time of the report, PRODUCT TEMPERATURE EXCURSION ISSUE (Refrigeration excursions identified/undergone several temperature excursions), POOR QUALITY PRODUCT ADMINISTERED (Vaccines have undergone several temperature excursions and may have been administered to patient) and NO ADVERSE EVENT (No adverse event) outcome was unknown.           No concomitant medication was provided.  On an unknown date, patient had received dose 1, dose 2, dose 3 of moderna vaccines. Route was Intramuscular and body site was deltoid for all three doses. Patient had received on deltoid body site for dose 4.     Treatment medication was not provided by the reporter.
This study case was received from the investigator of a trial on 08 February 2013. A male subject had received the following vaccinations on 30 January 2013: ACAM2000 (lot number and route not reported) in the left arm, typhoid vaccine (manufacturer, lot number, route and site not reported) and anthrax vaccine (lot number, route and site not reported). The subject reported local site symptoms, productive cough, fatigue and joint pain at V2 but no clear cardiac/pulmonary symptoms. Rapid troponin was normal but lab troponin was 0.3 ng/mL. The subject was instructed for repeat troponin, ECG and referral but indicated he may not. Suspect possible myopericarditis, subclinical. Details of the subject's symptoms included: the same day the subject experienced itching at the smallpox vaccination (SPV) site. On 01 February 2013, the subject experienced coughing up phlegm and fatigue. On 03 February 2013, the subject experienced bubbling at the SPV site. On 05 February 2013, the subject experienced bilateral shoulder pain and bilateral elbow pain. On 07 February 2013, the subject had elevated troponin HC 0.30 ng/mL. The subject had irrelevant past medical history. No further information was available at the time of the report. The subject's outcome was not recovered. According to the investigator, the event of elevated Troponin was considered another important event and possibly related to vaccination. Per the Investigator, this represents a case of potential myopericarditis and was referred to the study's adjudication committee for assessment. Documents held by sender: None.
Please received Pfizer booster. Within 2 minutes of observing pt felt dizzy, Blurry vision, anxious. Ringing in the ears, and light headed. Per mom, "pt started to lean to the right side then fell out of chair landing on rt shoulder." @ 1643. pt while being observed was given ice pack, head positioned on yoga mat, vitals taken, pt Denies pain. EMS called at 1648 and arrived at 1657. EMS assessed pt, vital signs taken also. EMS had pt sit up first then stand up and walked with her to sit in a chair. Pt declined additional care and mom declined as well. Mom will contact HCP if additional care is needed per Mom.
Patient was given an extra dose of HPV, spoke to doctor informed me that patient would be okay no side effects should be experienced.
A report has been received from a Health Professional concerning an 8 year old, Male subject, who had been receiving Nasal FLUMIST QUADRIVALENT. FLUMIST QUADRIVALENT started on 04-Dec-2013. It was reported that four patients were inadvertently administered expired FLUMIST quadrivalent which started on 04-Dec-2013. The outcome of the event of INADVERTENTLY ADMINISTERED EXPIRED FLUMIST QUADRIVLAENT is unknown. The report was considered to be non-serious.
been sick twice; Initial information received on 01-Dec-2022 regarding an unsolicited valid Social Media non-serious case received from a patient.  This case involves an unknown age and unknown gender patient and been sick twice after receiving influenza vaccine.  The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided.  On an unknown date, the patient received a dose of suspect influenza vaccine produced by unknown manufacturer (form, strength, dose, frequency, lot number, expiry date: unknown) via unknown route in unknown administration site for influenza.  On an unknown date the patient developed a non-serious event of been sick twice (illness) (unknown latency) following the administration of influenza vaccine.  Reportedly, Got mine, Been sick twice, I'll never get another one.  Action taken was not applicable.  It was not reported if the patient received a corrective treatment for the event (been sick twice).  At time of reporting, the outcome was Unknown for the event been sick twice.
Fever of 101.2F at highest, headache, chills, feeling very tired all appeared  at 5am on 3/14 the following morning after receiving vaccine.  Took Tylenol and slept until about 1:30pm.  At that time all symptoms except tiredness and slight headache were gone.  Took a few more hours for headache to go away and by next morning everything was back to normal.
Patient began experiencing symptoms approximately 1 week (7 days) after receiving the 2nd dose of the Pfizer/BioNTech vaccine series.  These symptoms included severe weakness/numbness of right hand and right food, moderate headache every day, migraine lasting 3 days resulting in emergency room visit, sharp nerve pain in back and neck.  Patient has been undergoing physical therapy for right hand weakness/numbness that is still continuing 30 days later, but improving slowly.  Per MRI and diagnosis from neurologist, concluded that patient has nerve inflammation secondary to receiving the vaccine.
Severe, debilitating headache.  I never get them.  Severe muscle, tendon pulling, cramping throughout body.  Weakness.  Right hand tremor. Symptoms lasted 3 days.  Headache continues although diminished in severity.
Pharmacist injected subcutaneously instead of intramuscularly. Patient experienced common side effects such as headache, localized site swelling (1 inch) and pain, body fatigue, and she also reported watery eyes. Patient took 2 doses of 600mg and 400mg ibuprofen the night of the vaccination and the morning after respectively. Patient's symptoms decreased over 2 days and has been resolved.
My pulse was high and I felt like it was going above 90 all the time even at rest above 100 like my heart was racing.  Metoprolol  was prescribed.
Severe chills and shivering with fever over 103F despite aspirin,      Fever declining to 102.5 40 hours after injection, mild fever 99F at 70 hours after injection (pt normal is 97.6F) Other symptoms included fatigue, inability to concentrate for 72 hours after injection.
Patient immediately following her first COVID-19 vaccination started having chronic seizures. This patient starts to develop slurred speech along with clenching her jaw and shaking uncontrollably. She was not arousable during the event. It took her an hour to come back to being able to speak clearly an become A&OX4. She stated to me today at work that she has had seizures daily since her first COVID-19 shot. Patient was prescribed Keppra today in our Emergency Department since no previous provider thought to prescribe her any medication to help with her seizures. She has been seen at 3 ED's and since these seizures started and seen by her PCP with no prior treatment.
Pt had itchy and warm to touch on (L) arm on 11-8-16. Pt didn't have redness until today 11-10-16.
HCP advised that her office administered vaccines that were reported being out of temperature on 2-24-23; Vaccine was administered to patient after temperature excursion occurred.; No adverse event; This spontaneous case was reported by an other health care professional and describes the occurrence of PRODUCT TEMPERATURE EXCURSION ISSUE (HCP advised that her office administered vaccines that were reported being out of temperature on 2-24-23), POOR QUALITY PRODUCT ADMINISTERED (Vaccine was administered to patient after temperature excursion occurred.) and NO ADVERSE EVENT (No adverse event) in a 70-year-old male patient who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (batch no. 05D22A) for COVID-19 prophylaxis.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) 1 dosage form. On an unknown date, the patient experienced PRODUCT TEMPERATURE EXCURSION ISSUE (HCP advised that her office administered vaccines that were reported being out of temperature on 2-24-23), POOR QUALITY PRODUCT ADMINISTERED (Vaccine was administered to patient after temperature excursion occurred.) and NO ADVERSE EVENT (No adverse event). At the time of the report, PRODUCT TEMPERATURE EXCURSION ISSUE (HCP advised that her office administered vaccines that were reported being out of temperature on 2-24-23), POOR QUALITY PRODUCT ADMINISTERED (Vaccine was administered to patient after temperature excursion occurred.) and NO ADVERSE EVENT (No adverse event) outcome was unknown.        For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessments were provided for PRODUCT TEMPERATURE EXCURSION ISSUE (HCP advised that her office administered vaccines that were reported being out of temperature on 2-24-23) and POOR QUALITY PRODUCT ADMINISTERED (Vaccine was administered to patient after temperature excursion occurred.).    No concomitant information was reported. Suspect product dosage text was reported as unknown. It was reported that no confirmation was provided on viability of vaccine vails and as a result office continued to perform vaccination with vials until 30-May-2023. Up to 14 vaccination were administered within this time line No treatment information was provided.   This case was linked to US-MODERNATX, INC.-MOD-2023-730480 (E2B Linked Report).; Sender's Comments:  US-MODERNATX, INC.-MOD-2023-730480:Same reporter
Patient was given a Pfizer Bivalent booster dose instead of a first dose of Primary Pfizer by Registered Nurse. No adverse reaction was noted,
Shortly after first vaccine, patient was hospitalized with COVID disease. This was not an AE to vaccine. However, vaccine providers are required to report if a patient receiving vaccination has to be hospitalized from COVID.
pt recv vax & devel approx 50 skin lesions all over body;the reporting MD felt pt exp was not r/t varicella vax;pt devel mild rash w/low grade temp;
Pt received DTaP, IPV, Hepatitis A vaccines 7/12/07. Pt had (L) thigh swelling, redness and pain. Pt seen at hosp 7/14/07 and given Benadryl. Pt saw me (doctor) 7/16/07 for re-evaluation. Pt's swelling, redness and pain resolved. Pt still had area of firmness on (L) thigh and bruising.
Initial report received from a health care professional in the USA on 09 May 2007. A 44 year old, female patient (with a medical history of known allergies, hypertension, non insulin dependent diabetes mellitus and hypercholesterolemia) developed body aches, redness and edema around the injection site, and pain from the injection site down the arm to fingers, one day after she received Adacel (lot number C2731AA) intramuscularly in the right deltoid on 07 May 2007. She did not have any laboratory or diagnostic tests done. She did not have any illness at the time of the vaccination. At the time of the report, she had not recovered. Same reporter as cases 2007-01631, 2007-01633 and 2007-01634.
This spontaneous report as received from a healthcare professional refers to a patient of unknown age and gender. It was reported that patient was administered a first dose of VARIVAX (Merck) on 20-OCT-2009 (18 days earlier that recommended age). Second dose of VARIVAX (Merck) was administered on 21-NOV-2013. No adverse effects reported. Additional information has been requested.
When I had COVID I had difficulty breathing. I had pain in my chest and towards the lungs. I had a chronic cough. I was also diagnosed with pneumonia. I had arthritis. I was prescribed an antibiotic for the pneumonia. Since I was a kid I ate fresh vegetables and fresh fruit. I feel like my healthy diet and indoor activities helped with my symptoms of COVID.
Hearing loss in left ear about a day after shot. Ear hurt as I suspected an infection. Went away after a couple of days. Hearing returned. Now my right ear is starting the same. Almost all hearing is gone same as my left ear did. Feels like and ear infection. Hope it comes back like the left ear.
Immediately felt pain + tingling. After 2 weeks still feels pain, cannot lift heavy things. But it is getting better, not debilitating pain, just bothersome.
accidentally administered 1 dose of Moderna COVID-19 Vaccine for 6 months to 5 years that was previously reconstituted with 1.3 mL of normal saline; No adverse event; On 06-APR-2023 a colleague accidentally administered 1 dose of Moderna COVID-19 Vaccine for 6 months to 5 years that was previously reconstituted with 1.3 mL of normal saline; This spontaneous case was reported by an other health care professional and describes the occurrence of PRODUCT PREPARATION ERROR (accidentally administered 1 dose of Moderna COVID-19 Vaccine for 6 months to 5 years that was previously reconstituted with 1.3 mL of normal saline), POOR QUALITY PRODUCT ADMINISTERED (On 06-APR-2023 a colleague accidentally administered 1 dose of Moderna COVID-19 Vaccine for 6 months to 5 years that was previously reconstituted with 1.3 mL of normal saline) and NO ADVERSE EVENT (No adverse event) in a 1-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. AS1417B) for COVID-19 prophylaxis.     No Medical History information was reported.    On 06-Apr-2023, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .25 milliliter. On 06-Apr-2023,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced POOR QUALITY PRODUCT ADMINISTERED (On 06-APR-2023 a colleague accidentally administered 1 dose of Moderna COVID-19 Vaccine for 6 months to 5 years that was previously reconstituted with 1.3 mL of normal saline). On an unknown date, the patient experienced PRODUCT PREPARATION ERROR (accidentally administered 1 dose of Moderna COVID-19 Vaccine for 6 months to 5 years that was previously reconstituted with 1.3 mL of normal saline) and NO ADVERSE EVENT (No adverse event). At the time of the report, PRODUCT PREPARATION ERROR (accidentally administered 1 dose of Moderna COVID-19 Vaccine for 6 months to 5 years that was previously reconstituted with 1.3 mL of normal saline), POOR QUALITY PRODUCT ADMINISTERED (On 06-APR-2023 a colleague accidentally administered 1 dose of Moderna COVID-19 Vaccine for 6 months to 5 years that was previously reconstituted with 1.3 mL of normal saline) and NO ADVERSE EVENT (No adverse event) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessments were provided for PRODUCT PREPARATION ERROR (accidentally administered 1 dose of Moderna COVID-19 Vaccine for 6 months to 5 years that was previously reconstituted with 1.3 mL of normal saline) and POOR QUALITY PRODUCT ADMINISTERED (On 06-APR-2023 a colleague accidentally administered 1 dose of Moderna COVID-19 Vaccine for 6 months to 5 years that was previously reconstituted with 1.3 mL of normal saline).    Patient's relevant medical history/conditions, allergy, concomitant diseases and risk factor were not known. Patient did not receive any other vaccines in the 4 weeks prior to COVID-19 vaccine. Concomitant medication details not reported by the reporter. Treatment details was not reported by the reporter.
This spontaneous report as received from a physician refers to two unspecified patients. The reporter stated that two doses of VARIVAX that were improperly stored at a high temperature of 10F for less than 1 hour, were administered to two unspecified patients on 29-MAY-2014 (one dose, 0.5 ml, subcutaneously, LOT# and expiration date were not reported). No adverse effects were reported. Additional information has been requested.
Strong headache; Joints pain; Very sleepy; This is a spontaneous report from a contactable consumer, the patient. A 35-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 05Jul2021 at 14:00 (at the age of 35-year-old) as a single dose for COVID-19 immunisation. Medical history was not reported. Prior to the vaccination, the patient was not diagnosed with COVID-19.  It was not known whether the patient had any allergies to medications, food, or other products. The patient did not take any concomitant medication. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 05Jul2021 at 23:00, the patient experienced strong headache, joints pain and very sleepy. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The patient did not receive any treatment for the reported event. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events strong headache, joints pain and very sleepy were unknown.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
tendinitis and joint point not connected to current injury or overuse beginning with feet and ankles, then hands and wrists by 8/7, throughout body by 8/8. Dx 8/9 as polymyalgia rheumatica, blood work drawn and sent to lab; started diclofenac 75mg bid
Was observed post Covid-19 immunization for 30 minutes based on pre-vaccination screening .  During the observation period, she experienced an adverse reaction with the following symptoms:  anaphylaxis, difficulty breathing, dizziness, nausea and rapid heart rate. Disposition: Patient evaluated and transferred to the hospital for further evaluation and care. Time of transport: 1537. Patient began coughing. Nurse offered patient a bottle of water but patient signaled she could not swallow. Nurse then obtained vital signs for this patient which are listed above. EMT notified immediately. Report and care transferred to EMT.
Flu like symptoms; it was hard to keep stuff down; heightened anxiety; stomachache; vomiting; exhausted; running a fever; chills; This spontaneous case was reported by a consumer and describes the occurrence of INFLUENZA LIKE ILLNESS (Flu like symptoms), MOBILITY DECREASED (it was hard to keep stuff down), ANXIETY (heightened anxiety), ABDOMINAL PAIN UPPER (stomachache) and VOMITING (vomiting) in a 44-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 03TBZ1A and 04B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included Post-traumatic stress disorder, Anxiety, Concussion (4 concussions), Traumatic brain injury and Memory disturbance. Concomitant products included ATENOLOL for Palpitations, SERTRALINE for Post-traumatic stress disorder, TRAZODONE for Sleep disorder, PRAZOSIN and VITAMIN D NOS for an unknown indication.   On 13-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 09-May-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 13-Apr-2021, the patient experienced INFLUENZA LIKE ILLNESS (Flu like symptoms), MOBILITY DECREASED (it was hard to keep stuff down), ANXIETY (heightened anxiety), ABDOMINAL PAIN UPPER (stomachache), VOMITING (vomiting), FATIGUE (exhausted), PYREXIA (running a fever) and CHILLS (chills). On 16-Apr-2021, ANXIETY (heightened anxiety), ABDOMINAL PAIN UPPER (stomachache), PYREXIA (running a fever) and CHILLS (chills) had resolved. At the time of the report, INFLUENZA LIKE ILLNESS (Flu like symptoms), MOBILITY DECREASED (it was hard to keep stuff down), VOMITING (vomiting) and FATIGUE (exhausted) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Treatment for the events were not provided.The patient was expected to receive second dose after 25 days on MAY 09,2021 the vaccination facility refuses to provide her the second dose today as it is 2 days early. Past medical history included hit and runs too. .Patient blood pressure normally runs a little low and the medications were not used for the blood pressure maintenance.   Most recent FOLLOW-UP information incorporated above includes: On 13-May-2021: Second dose details were provided
I got my COVID-19 Vaccine on 11/30/2021, and on 12/07/2021, I had a weird incident where I felt like I was passing out, I was not sure what was going on, felt like I was going in and out of consciousness, and that went on for like once a week, and then I went to a cardiologist, and all my test came back negative, my primary care Dr. suggested that I go to cardiology and neurology, I was on the wait list for many months, and I kept going to the cardiologist and all my test came back negative, after six months I finally got a chance to see neurology and they said that I have been having seizures. They cannot tell what kind of seizures that I am having, or the reason on why I am having them. The Dr.'s don't know how it started or why I keep having it. The Dr. prescribed me KEPPRA after six months and I still had seizures, and they prescribed me LAMICTAL and I have been on for six months and I have been seizure free for six months. The overall of this is I am not sure if this is related to the vaccine, I have no family related to neurological issues and I know that this started a week after I had the vaccine and lasted up until the last six months. I have different types of seizures, per the people around me, my body would just drop and my eyes would flutter, and some minimal convulsing was seen with my head jerking back, and then the second was when I was seeing a psychologist for ADHD, and during the test, I was unresponsive for 2 min. I looked away and was unresponsive. Per that Dr. and my neurologist, they said that I could be having seizure's and not knowing it. And only three times did I experience full body convulsing's with my head back and my body jerking up and down.
Low grade fever (99.7- 100.8) from about 9:00 pm  on 4.13.2021 to 8:00 am on 4.15.2021, intense brain fog (from about 6:00 pm on 4.13.2021-- still experiencing at 4:30 pm on 4/15/2021), fatigue (from about 6:00 pm on 4.13.2021 and still experiencing on 4/15/2021).